Top 5 Stocks Warren Buffett Just Bought

Bristol-Myers Squibb (NYSE:BMY) is the first of three healthcare stocks that top the list of Warren Buffett’s biggest buys of Q3, all of which rank among the 10 Biggest Pharmaceutical Companies in the World in 2020. Berkshire bought 29.97 million BMY shares during Q3, valued at $1.81 billion on September 30.

BMY shares have fallen by over 7% over the last five years as the market grows increasingly concerned about the looming loss of exclusivity over some of Bristol-Myers’ most successful drugs like Revlimid. In its Q3 investor letter, Generation PCMA expressed confidence in BMY’s pipeline, including TYK-2, Opvido, Ozanimod, and Zeposia, and believes that future acquisitions can also help offset those losses. The fund believes BMY’s fair market value is $75, nearly 20% higher than its current share price.